IP Library Assignment 014226/0037
Patent Assignment
Reel/Frame 014226/0037

Assignment of Assignor's Interest

Recorded: 2003-06-30 Pages: 4
Assignors
KLYOSOV, ANATOLE
Executed: 2003-04-16
PLATT, DAVID
Executed: 2003-04-16
Assignee
PRO-PHARMACEUTICALS, INC.
189 WELLS AVENUE, NEWTON, MASSACHUSETTS, 02459
Covered Property (1)
Methods and compositions for reducing side effects in chemotherapeutic treatments
Application: 10/354,750 →
Publication: US 2003/0229028
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Claims Jun 4, 2007
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 019365/0510 →
Change of Name Jun 4, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 019365/0638 →
Assignment of Assignor's Interest Jun 4, 2007
From: PLATT, DAVID
To: GLYCOGENESYS, INC.
Reel/Frame 019375/0467 →
Court Appointment of Trustee Jun 4, 2007
From: GLYCOGENESYS, INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
Reel/Frame 019365/0501 →
Change of Name Jun 4, 2007
From: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
To: PROSPECT PHARMACEUTICALS, INC.
Reel/Frame 019365/0633 →
Security Agreement Aug 26, 2009
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023134/0968 →
Release of Security Interest Sep 17, 2019
From: 10X FUND L.P.
To: GALECTIN THERAPEUTICS, INC.
Reel/Frame 050399/0679 →